Journal of Laparoendoscopic & Advanced Surgical Techniques | VOL. 32
Read

Robot-Assisted Mini-Endoscopic Combined Intrarenal Surgery for Complex and Multiple Calculi: What Are the Real Advantages?

Publication Date Aug 1, 2022

Abstract

Background: To determine the stone-free rates (SFR) with robot-assisted mini-endoscopic combined intrarenal surgery (mini-ECIRS) and evaluate the impact of intraoperative assessment of stone-free status compared to postoperative non-contrast computed tomography (NCCT) scan findings. Methods: A total of 42 consecutive patients (44 renal units) diagnosed with complex/multiple renal stones were enrolled and reviewed in a retrospective manner. While retrograde access with the flexible scope was performed by using Avicenna Roboflex, mini-percutaneous nephrolithotomy was performed through a 16.5F sheath. Demographic, clinical characteristics of the cases along with perioperative complications were recorded, analyzed, and compared to the reported data in the literature. Results: Forty-two renal units (95.5%) were endoscopically confirmed to be stone-free at the end of the procedure, of which all were confirmed to be stone-free in postoperative NCCT examination. Complications were observed in 3 of the 42 (7.1%) patients, which were classified as Clavien grade I. The mean operation and fluoroscopy time were 103.7 ± 20.6 minutes and 71 ± 13.7 seconds, respectively. Conclusion: Our results demonstrate that robot-assisted mini-ECIRS could reveal high SFR in complex and multiple stones. In addition, endoscopic flexible ureteroscopic evaluation of the collecting system at the end of the procedure could let the surgeon predict stone-free status more reliably and successfully.

Concepts

Avicenna Roboflex Mini-percutaneous Nephrolithotomy Non-contrast Computed Tomography Retrograde Access Stone-free Status Clavien Grade Flexible Scope Multiple Calculi Multiple Stones Stone-free Rates

Round-ups are the summaries of handpicked papers around trending topics published every week. These would enable you to scan through a collection of papers and decide if the paper is relevant to you before actually investing time into reading it.

Coronavirus Research Articles published between Sep 26, 2022 to Oct 02, 2022

R DiscoveryOct 03, 2022
R DiscoveryArticles Included:  5

Introduction: Test solutions (Biotrue, renu Advanced [Bausch and Lomb], ACUVUE RevitaLens [Johnson and Johnson Vision], cleadew [Ophtecs corp.] or AOS...

Read More

Good health Research Articles published between Sep 26, 2022 to Oct 02, 2022

R DiscoveryOct 03, 2022
R DiscoveryArticles Included:  2

Patient and public involvement in health care is considered indispensable in the way we conduct daily pediatric neurology practice, and in the develop...

Read More

Quality Of Education Research Articles published between Sep 26, 2022 to Oct 02, 2022

R DiscoveryOct 03, 2022
R DiscoveryArticles Included:  5

Ingenta is not the publisher of the publication content on this website. The responsibility for the publication content rests with the publishers prov...

Read More

Gender Equality Research Articles published between Sep 26, 2022 to Oct 02, 2022

R DiscoveryOct 03, 2022
R DiscoveryArticles Included:  3

Introduction: As of early March 2022, the COVID-19 pandemic has killed more 5.9 million people worldwide, and infected more than 437 million.

Read More

Coronavirus Pandemic

You can also read COVID related content on R COVID-19

R ProductsCOVID-19

ONE PROBLEM . ONE PURPOSE . ONE PLACE

Creating the world’s largest AI-driven & human-curated collection of research, news, expert recommendations and educational resources on COVID-19

COVID-19 Dashboard

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on “as is” basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The Copyright Law.